Guidance for Obagi Medical Products, Inc. (OMPI)
| Period |
Range |
Estimate |
Revenue Range |
Revenue Estimate |
Target |
Details |
| 2013 |
$0.80 – 0.84 |
$0.88 |
$126.00M – 130.00M |
$129.20M |
 Lowered |
Details |
| 2012 |
$0.58 – 0.62 |
$0.60 |
$119.00M – 124.00M |
$122.94M |
= Maintained |
Details |
| 2012 |
$0.89 – 0.91 |
$0.89 |
N/A |
N/A |
= Maintained |
Details |
| 2012 |
$0.62 – 0.63 |
$0.61 |
$119.50M – 120.50M |
$121.93M |
= Maintained |
Details |
| Q4 2012 |
$0.12 – 0.13 |
$0.15 |
$29.00M – 30.00M |
$31.80M |
= Maintained |
Details |
| Q3 2012 |
$0.12 – 0.13 |
$0.14 |
$27.50M – 28.50M |
$30.02M |
= Maintained |
Details |
| Q1 2012 |
$0.10 – 0.11 |
$0.20 |
$27.00M – 29.00M |
$28.05M |
= Maintained |
Details |
| 2011 |
$0.87 – 0.91 |
$0.83 |
$119.00M – 122.00M |
$121.00M |
= Maintained |
Details |
| 2011 |
$0.78 – 0.78 |
$0.89 |
$114.00M – 116.00M |
$120.60M |
= Maintained |
Details |
| Q3 2011 |
$0.16 – 0.17 |
$0.18 |
$27.00M – 28.50M |
$28.00M |
= Maintained |
Details |
| Q2 2011 |
$0.15 – 0.17 |
$0.23 |
$26.50M – 28.00M |
$30.67M |
= Maintained |
Details |
| Q1 2011 |
$0.11 – 0.12 |
$0.12 |
$26.00M – 27.00M |
$28.00M |
= Maintained |
Details |
